EchoRef vs COAPT Risk Score

EchoRef is a free iOS ultrasonography educational reference covering point-of-care ultrasound (POCUS), transthoracic echocardiography (TTE), and transesophageal echocardiography (TEE). Additionally, it contains cardiac dimensions, native/prosthetic valve measurements, hemodynamic/ultrasound calculations, and lessons ranging from interventional procedures to mechanical circulatory support. This app is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition, and never disregard or delay seeking professional advice because of information provided by this app. About Rishi Kumar, MD, FACC ("RK.MD") I'm an adult cardiothoracic anesthesiologist and cardiovascular ICU intensivist practicing in academic medicine. I'm passionate about teaching with free, open-access medical education. Learn more on my site: https://rk.md

For educational purposes and for use by medical professionals only. For patients with severe functional mitral regurgitation and symptomatic heart failure (left ventricular ejection fraction between 20-50%) despite best medical therapy. The COAPT Risk Score is a simple risk prediction tool created by combining clinical and echocardiographic variables in patients with heart failure (HF) and moderate-to-severe or severe functional mitral regurgitation (FMR) who remain symptomatic despite maximally tolerated guideline directed medical therapy (GDMT). The COAPT Risk Score provides valuable prognostic information regarding the 2-year risk of death and/or heart failure hospitalization (HFH). The score is derived from the COAPT trial population of patients with HF and moderate-to-severe or severe FMR randomized to treatment with either transcatheter edge-to-edge repair (TEER) with MitraClip plus GDMT or GDMT alone. We can incorporate TEER in the risk score and provide updated 2-year risk of death and/or HFH which can serve as a valuable shared decision-making tool for patients and physicians as well as heart teams while deciding about TEER. Created by a team of subject-matter experts including: the director of The Mount Sinai Hospital cardiac cath lab Dr. Kini, Director of Clinical and Interventional Cardiology at the Mount Sinai Health System Dr Sharma, the Mount Sinai Hospital Surgical Director Dr. Tang, COAPT Principal Investigator Dr. Stone, and COAPT Risk Score publication author Dr. Shah.